Codexis, Inc. (CDXS)
1.82
-0.04
(-2.41%)
USD |
NASDAQ |
Dec 10, 16:00
1.82
0.00 (0.00%)
After-Hours: 19:35
Codexis EPS Diluted (Quarterly): -0.2173 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 2.316 |
| EyePoint Pharmaceuticals, Inc. | -0.8513 |
| Tarsus Pharmaceuticals, Inc. | -0.2954 |
| CEL-SCI Corp. | -1.365 |
| AIM ImmunoTech, Inc. | -1.569 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -19.62M |
| Revenue (Quarterly) | 8.601M |
| Total Expenses (Quarterly) | 28.22M |
| Enterprise Value | 177.89M |
| Gross Profit Margin (Quarterly) | 56.02% |
| Profit Margin (Quarterly) | -228.1% |
| Earnings Yield | -41.28% |
| Normalized Earnings Yield | -39.86 |